Simplify Your COVID-19 Vaccine Coding
Coding for COVID-19 vaccines can be complicated, with specific codes for vaccine presentations, patient age, and dose administered. But finding the right codes for Moderna’s products just got easier.
Accessing the Coding for reimbursement tool
When using the tool, simply answer a few questions, and it will generate the codes you need. Then, just copy and paste them into your EMR or print the codes for future reference.
To retrieve updated coding as new presentations are introduced, make sure you bookmark the page.
How To Use LUCIRA by Pfizer
LUCIRA by Pfizer COVID-19 & Flu Home Test is the ONLY over-the-counter test that allows you to skip the wait and see results from the comfort of your home.
Available July 1: the first over-the-counter test that offers fast and accurate testing for both COVID-19 and Flu A/B
Beginning July 1, 2024, the LUCIRA by Pfizer COVID-19 & Flu Test will be available to order for all PRN members. This cordless device gives you results in 30 minutes, showing a positive result in as few as 11 minutes.
LUCIRA by Pfizer COVID-19 and Flu A & B test offers the convenience of an in-office test with molecular testing and PCR-quality accuracy for ages 2 and up.
Swab, stir and detect. 3 simple steps with an easy-to-read display. Click on the image below for more details.
Novavax: Prebook/reservation Deadline Extension
Moderna Information to Support Your Immunization Needs
Moderna is here to support your immunization efforts. Ensure your team is ready for the upcoming COVID-19 season by reserving your vaccine supply today.
Click the links below for more information:
2024-2025 Expected Presentation: Spikevax (COVID-19 Vaccine, mRNA) - 12 years of age and older
Updated COVID-19 Vaccination Recommendation for those 65 and Older
Available April 1: The only FDA-approved vaccine that helps prevent all 5 leading types of meningococcal meningitis
Source: www.penbraya.com
PENBRAYA is available for order beginning April 1, 2024. PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. PENBRAYA is approved for use in individuals 10 through 25 years of age.
PENBRAYA combines 2 vaccines that have nearly 10 years of experience to help protect against all 5 leading types of meningitis—A, B, C, W, and Y. Patients can now get the broadest protection against all 5 leading types of meningococcal meningitis with the fewest shots.
Click here for more information.
If you are interested in ordering, please contact Tina Clark, Contract Administrator, at tina@prn-gpo.com or (888)776-2360.
Save 6% now on MenQuadfi® Meningococcal Group A, C, W and Y Conjugate Vaccine
Sanofi is offering a 6% sales promotion on all MenQuadfi® Meningococcal Group A, C, W and Y Conjugate Vaccine orders placed between February 5, 2024 and March 31, 2024. You can schedule MenQuadfi® orders to ship immediately or future ship through October 31, 2024 on VaccineShop.com or VaxServe.com. Scheduling orders now can help you manage your inventory throughout the back-to-school season.
If you have any additional questions, please feel free to contact a Sanofi representative or call Sanofi’s customer service at 1-800-822-2463.
Empower Your COVID-19 Fight: Essential Vaccine Insights
As we navigate a world where COVID-19 is one of many health concerns, your commitment to patient care remains invaluable. Your expertise and counsel continue to play a crucial role in disease prevention and patient health.
With the number of COVID-19 hospitalizations topping 19,000 the week of November 19 – 25, 2023, vigilance and preventative measures remain essential. The ACIP continues to recommend updated COVID vaccines for all patients aged 6 months and older, and your guidance can make a powerful difference.
To assist you, Moderna has assembled a concise resource that sheds light on the latest research and the importance of extended vigilance in combatting the spread of the SARS-CoV-2 virus.
The role of healthcare professionals is pivotal in guiding vaccine decisions. Studies show that messages involving a personal physician or a scientist recommending vaccination were the most compelling ways to improve vaccine adherence.
Together, we continue to strive to protect patients from COVID-19. Thank you for your relentless dedication and the difference you make every day.
For inquiries call 1-866-MODERNA (1-866-663-3762).